Fuxin Ma

Fuxin Ma

Auto-generated profile, based on publicly available information

Fuxin Ma

School of Pharmacy, Fujian Medical University, Fuzhou, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2023 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
JCJiana Chen
Jiana Chen
ZZZhiwei Zeng
Zhiwei Zeng
ZFZongwei Fang
Zongwei Fang
FMFuxin Ma
Fuxin Ma
MLMeina Lv
Meina Lv
JZJinhua Zhang
Jinhua Zhang
Background: Thrombolysis-related intracranial hemorrhage has a high mortality rate, and many factors can cause intracranial hemorrhage. Until now, systematic reviews and assessments of the certainty of the evidence have not been updated.Aim: We conducted a systematic review to identify risk factors for thrombolysis-related intracranial hemorrhage.Method: The protocol for this systematic review was prospectively registered with PROSPERO (CRD42022316160). All English studies that met the inclusion criteria published before January 2022 were obtained from PubMed, EMBASE, Web of Science, and Cochrane Library. Two researchers independently screened articles, extracted data, and evaluated the quality and evidence of the included studies. Risk factors for intracranial hemorrhage were used as the outcome index of this review. Random or fixed-effect models were used in statistical methods.Results: Of 6083 citations, we included 105 studies in our analysis. For intracranial hemorrhage, moderate-certainty evidence showed a probable association with age, National Institutes of Health stroke scale, leukoaraiosis, hypertension, atrial fibrillation, diabetes, total cholesterol, proteinuria, fibrinogen levels, creatinine, homocysteine, early infarct signs, antiplatelet therapy and anticoagulant therapy; In addition, we found low-certainty evidence that there may be little to no association between risk of intracranial hemorrhage and weight, sex, platelet count, uric acid, albumin and white matter hyperintensity. Leukoaraiosis, cardiovascular disease, total cholesterol, white blood cell count, proteinuria, fibrinogen levels, creatinine, homocysteine and early CT hypodensities are not included in most intracranial hemorrhage risk assessment models.Conclusion: This study informs risk prediction for thrombolysis-related intracranial hemorrhage, it also informs guidelines for intracranial hemorrhage prevention and future research.

20 January 2023 in Neurocritical Care
Verified
Journal Article
Closed access
PDF file
ZZZhiwei Zeng
Zhiwei Zeng
JCJiana Chen
Jiana Chen
JQJiafen Qian
Jiafen Qian
FMFuxin Ma
Fuxin Ma
MLMeina Lv
Meina Lv
JZJinhua Zhang
Jinhua Zhang


18 August 2022 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
ZZZhiwei Zeng
Zhiwei Zeng
JCJiana Chen
Jiana Chen
MCMingrong Chen
Mingrong Chen
FMFuxin Ma
Fuxin Ma
MLMeina Lv
Meina Lv
JZJinhua Zhang
Jinhua Zhang

17 April 2024 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
FMFuxin Ma
Fuxin Ma
ZZZhiwei Zeng
Zhiwei Zeng
JCJiana Chen
Jiana Chen
JZJinhua Zhang
Jinhua Zhang

25 October 2024 in Annals of Hematology
Verified
Journal Article
Open access
PDF file
FMFuxin Ma
Fuxin Ma
ZZZhiwei Zeng
Zhiwei Zeng
JCJiana Chen
Jiana Chen
JZJinhua Zhang
Jinhua Zhang